Phase II study of tepotinib in NSCLC patients with METex14 mutations Meeting Abstract
| Authors: | Paik, P. K.; Veillon, R.; Cortot, A. B.; Felip, E.; Sakai, H.; Mazieres, J.; Griesinger, F.; Horn, L.; Senellart, H.; Van Meerbeeck, J. P.; Carpeno, J. D.; Patel, J. D.; Garassino, M. C.; Morise, M.; Reinmuth, N.; Viteri, S.; Tokito, T.; Sakamoto, T.; Scheele, J.; Le, X. |
| Abstract Title: | Phase II study of tepotinib in NSCLC patients with METex14 mutations |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 478s |
| Language: | English |
| ACCESSION: | WOS:000487345806450 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.9005 |
| Notes: | Meeting Abstract: 9005 -- Source: Wos |
